PT Prodia Widyahusada Tbk

Jakarta Stock Exchange PRDA.JK

PT Prodia Widyahusada Tbk Revenue for the year ending December 31, 2023: USD 144.46 M

PT Prodia Widyahusada Tbk Revenue is USD 144.46 M for the year ending December 31, 2023, a 3.46% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

PT Prodia Widyahusada Tbk Revenue for the year ending December 31, 2022 was USD 139.63 M, a -24.79% change year over year.
PT Prodia Widyahusada Tbk Revenue for the year ending December 31, 2021 was USD 185.66 M, a 41.58% change year over year.
PT Prodia Widyahusada Tbk Revenue for the year ending December 31, 2020 was USD 131.14 M, a 4.42% change year over year.
PT Prodia Widyahusada Tbk Revenue for the year ending December 31, 2019 was USD 125.59 M, a 13.77% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Jakarta Stock Exchange: PRDA.JK

PT Prodia Widyahusada Tbk

CEO	Ms. Dewi Muliaty
IPO Date	Dec. 9, 2016
Location	Indonesia
Headquarters	Prodia Tower
Employees	2,974
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals

Description

PT Prodia Widyahusada Tbk provides private clinical laboratory services. The company offers laboratory, panel test, and other diagnostics support services. As of December 31, 2021, it operated 259 outlets comprising 10 Prodia Health Care and specialty clinic outlets, 142 clinical lab and medical labs, 98 point of care outlets, and 9 hospital collaboration labs in 34 provinces throughout Indonesia. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk is a subsidiary of PT Prodia Utama.

Key trends

Past 5 years